GABA Transaminase Inhibitor (unspecified)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GABA Transaminase Inhibitor (unspecified), covering 2025-07-30 to 2025-07-30. Get the full timeline:
Most recent: Clinical Trial Update: Inhibiting GABA Transaminase to Relieve Obesity Induced Hyperinsulinemia and Insulin Resistance [Phase 2]